The MRP-L15 Activators chemical class includes compounds that can indirectly affect the activity of MRP-L15 through their influence on mitochondrial function and protein synthesis. For example, compounds that affect mitochondrial ATP production, such as oligomycin, can change the energetic environment of the mitochondrion, which could lead to adjustments in the mitochondrial protein synthesis machinery, including the activity of ribosomal proteins like MRP-L15.
Consider how compounds like resveratrol and bezafibrate, which have been associated with enhanced mitochondrial biogenesis and function, might lead to an increased demand for mitochondrial protein synthesis, upregulating MRP-L15 activity. Similarly, AMPK activators like AICAR and metformin can modulate mitochondrial metabolism, which may influence MRP-L15 activity due to changes in mitochondrial protein synthesis requirements. SIRT1 activators and NAD+ precursors like SRT1720 and NMN, respectively, could also impact mitochondrial function and, as a result, mitochondrial protein synthesis. Meanwhile, modulation of the mTOR pathway by compounds such as leucine and rapamycin could influence the overall rate of protein synthesis, including that of mitochondrial-encoded proteins. Coenzyme Q10, as a mitochondrial support agent, might also contribute to an environment that enhances the function of MRP-L15. These compounds do not directly interact with MRP-L15 but could impact its activity by influencing the broader context of mitochondrial function and protein s
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Oligomycin | 1404-19-9 | sc-203342 sc-203342C | 10 mg 1 g | $146.00 $12250.00 | 18 | |
An inhibitor of mitochondrial ATP synthase that can affect mitochondrial function, potentially altering MRP-L15 activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
May enhance mitochondrial function and biogenesis, possibly leading to increased demand for mitochondrial protein synthesis. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $30.00 $45.00 $120.00 $200.00 | 5 | |
A fibrate drug that can induce mitochondrial biogenesis, potentially affecting MRP-L15 activity. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $60.00 $270.00 $350.00 | 48 | |
Activates AMPK which can influence mitochondrial metabolism and potentially MRP-L15 activity. | ||||||
Methylene blue | 61-73-4 | sc-215381B sc-215381 sc-215381A | 25 g 100 g 500 g | $42.00 $102.00 $322.00 | 3 | |
May enhance mitochondrial function and oxidative phosphorylation, indirectly affecting MRP-L15. | ||||||
SRT1720 | 1001645-58-4 | sc-364624 sc-364624A | 5 mg 10 mg | $193.00 $357.00 | 13 | |
A SIRT1 activator that can influence mitochondrial biogenesis, potentially affecting MRP-L15 activity. | ||||||
L-Leucine | 61-90-5 | sc-364173 sc-364173A | 25 g 100 g | $21.00 $61.00 | ||
An amino acid known to stimulate mTOR, which can enhance protein synthesis, possibly affecting mitochondrial proteins. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that can modulate protein synthesis, potentially affecting MRP-L15 activity. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $77.00 | 2 | |
Can activate AMPK and affect mitochondrial function, potentially influencing MRP-L15 activity. | ||||||
β-Nicotinamide mononucleotide | 1094-61-7 | sc-212376 sc-212376A sc-212376B sc-212376C sc-212376D | 25 mg 100 mg 1 g 2 g 5 g | $92.00 $269.00 $337.00 $510.00 $969.00 | 4 | |
A NAD+ precursor that may enhance mitochondrial function, indirectly affecting MRP-L15. |